Latest ArticlesThe emergency medicine stockpile is an important guarantee for medical rescue in serious incident and a major part of the construction of the national emergency management system. This paper summarized the current regulations, mode and application of emergency medicine stockpile and using management in China, and analyzed the current problems from the aspects of system design, catalog formulation, management team and platform construction, and proposed some recommendations and countermeasures, so as to provide reference for the development of emergency medicine stockpile system in China.
The operation and management of emergency dispensaries in designated hospitals for the coronavirus disease 2019 (COVID-19) is one of the important links for the effectiveness of epidemic prevention and control. Based on my own experience in the establishment and operation of emergency pharmacy in a designated hospital in Shanghai, the author introduced the construction and operation management of emergency pharmacy in designated hospitals in detail from the aspects of management mechanism construction, emergency drug catalogue formulation, personnel management training, drug procurement and deployment process, narcotic drug management, etc. The operation and management of emergency dispensaries in designated hospitals can meet the treatment needs of different types of patients in the early and the middle and late stage of COVID-19 outbreak, ensure drug supply, ensure the rational and safe use of drugs for patients, and reduce the risk of hospital cross infection among medical staff, provide reference for the standardized management of emergency dispensary under the global outbreak of infectious diseases.
To summarize the pharmaceutical practices in establishing a general pharmacy and carrying out pharmacy practice in clean areas after hospital being assigned as a designated hospital for treating patients infected with the new Omicron variant of coronavirus, so as to provide a reference for the other pharmacy departments to deal with public health emergencies in terms of operation and management.
Analyze the practice of comprehensive pharmacies in the clean area, including the pharmacy site selection, function integration of pharmacies, reconstruction of system norms, supply of special drugs and disinfectants, construction of drug safety information system, special post setting and rational arrangement of personnel, etc.
It is feasible for the pharmacy department of a designated hospital to establish a general pharmacy in the clean area. The general pharmacy integrated the functions of outpatient and emergency pharmacies, inpatient pharmacy, pharmacy intravenous admixture services and other pharmacies, reconstructed job responsibilities and work process, arranged personnel rationally, made use of space. WeChat app and pre-prescription review system were utilized to ensure the drug supply and medication safety. Comprehensive epidemic prevention measures were carried out to guarantee the safety of the staff.
Establishing a general pharmacy in the clean area can fulfill the requirement of clinical diagnosis and treatment in a designated hospital, and this new mode provides a valuable example for pharmacy departments of medical institutions when major public health emergencies occur in the future.
With the wide application of nuclear technology in industry, agriculture, medicine, military and many other fields, nuclear accident has become a public health emergency that seriously damages public health, causing great panic and harm to human beings. At present, there are some anti-radiation damage drugs with good protective effects, but their side effects cannot be ignored. Therefore, it has become an urgent problem to actively search for new type of high efficiency and low toxicity anti-radiation drugs. This article reviewed the research progress of anti-radiation drugs from the perspective of chemical drugs, biological products, traditional Chinese medicine and natural medicine, in order to provide a theoretical basis for the development and application of anti-radiation drugs.
To study the effects of sodium valproate on pancreatic islet β cells and SKAP2/NF-κB pathway in diabetic mice.
Seventy-five male C57BL/6J mice were randomly divided into 5 groups: normal group, model group, low-dose sodium valproate group (200 mg·kg-1·d-1), high-dose sodium valproate group (400 mg·kg-1·d-1), positive control group (metformin, 200 mg·kg-1·d-1). Except for the normal group, the other mice were given streptozotocin (STZ, 50 mg/kg) solution for 5 consecutive days to establish a diabetes model, and the subsequent intragastric treatment lasted for 5 weeks. Plasma insulin, fasting blood glucose and oral glucose tolerance were determined. Hematoxylin-eosin (HE) was used to detect pancreatic pathological changes. TUNEL was used to detect β-cell apoptosis. Western blot was used to detect pancreatic Src kinase-associated phosphoprotein 2 (SKAP2), nuclear factor-κB (NF-κB) p65, C/EBP-homologous protein (CHOP) and Caspase-3 express.
Compared with the normal group, the fasting blood glucose was increased, glucose tolerance level and plasma insulin level of the model group were decreased, pancreatic injury and β-cell apoptosis rate were significantly increased, and expression of NF-κB p65, caspase-3 and CHOP in pancreatic tissue were significantly increased, and the expression of SKAP2 was significantly decreased (P<0.01). Compared with the model group, the above detection indexes in the three treatment groups were significantly improved, and the sodium valproate group showed a certain dose-effect relationship.
Sodium valproate can regulate islet β cells in diabetic mice, and the mechanism may be related to the SKAP2/NF-κB pathway.
To investigate the relationship between visceral fat and syndrome types of traditional Chinese medicine (TCM) in patients with type 2 diabetes mellitus (T2DM), and to explore the related factors.
A total of 125 T2DM patients who met the inclusion criteria and were admitted to the inpatient Department of Endocrinology, LongHua Hospital Shanghai University of TCM from September 2018 to March 2020 were selected. According to the syndrome differentiation, the patients were divided into Qi and Yin deficiency group, dampness-heat trapped spleen group, Yin and Yang deficiency group, blood stasis and vein group. The general data, visceral fat and subcutaneous fat of each syndrome type were observed and compared, and the correlation was analyzed.
The course of disease in damp-heat trapped spleen group was shorter than the other three groups, and the difference was statistically significant compared with blood stasis vein group (P<0.05). 2-hour postprandial insulin (2hINS) in the damp-heat trapped spleen group was significantly higher than that in the other three groups, and the difference was statistically significant compared with the Qi and Yin deficiency groups (P<0.05). Serum uric acid (UA) was the lowest in Qi and Yin deficiency group, and the differences were statistically significant compared with the other three groups (P<0.05). There were significant differences in visceral fat and subcutaneous fat in the damp-heat trapped spleen group compared with the other three groups (P<0.01), and there was significant difference between Yin and Yang deficiency group and Qi and Yin deficiency group (P<0.05). There were significant differences in subcutaneous fat in blood stasis vein group compared with Qi and Yin deficiency syndrome, Yin and Yang deficiency group (P<0.05). Univariate linear regression analysis showed that UA, fasting insulin (FINS), 2hINS were positively correlated with visceral fat.
Visceral fat in T2DM patients is closely related to dampness-heat trapped spleen syndrome. FINS, 2hINS and UA are positively correlated with visceral fat.
To investigate the clinical features, diagnosis and treatment of infectious mononucleosis (IM) in children.
From January 2018 to February 2020, 36 children with IM in the department of pediatrics of Shanghai oriental hospital were selected as the research objects, and their clinical manifestations, laboratory tests and treatment were retrospectively analyzed.
There were 36 cases of IM children, the main clinical manifestations were lymphadenitis (97.22%), fever (86.11%), pharyngeal tonsillitis (77.78%), hepatomegaly (33.33%), splenomegaly (47.22%), eyelid edema (33.33%) and rash (8.33%). There were significant differences in the incidence of splenomegaly among children of different ages (P<0.05), and children of school age and adolescence were more likely to have splenomegaly than children. Leukocytes increased (61.11%), and heterotypic lymphocytes≥10% (94.44%). Epstein-Barr virus (EBV) antibodies, induding EBV-viral capsid antigen (VCA)-immunoglobulin (Ig)M antibody, EBV-VCA-IgG antibody, EBV-VCA-IgA antibody, EBV-early antigen (EA)-IgA antibody, EBV-EA-IgG antibody and EBV-nuclear antigen-IgG antibody, were detected in 33 children. The positive rates of them were 87.88%, 57.58%, 33.33%, 27.27%, 18.18% and 0, respectively. 14 cases were mycoplasma positive, 1 case was influenza virus positive and 1 case was rhinovirus positive. The complications were granulocytopenia (61.11%), liver function damage (52.78%), anemia (47.22%), myocardial damage (44.44%) and respiratory tract infection (41.67%). 88.89% of the children received antiviral therapy with ganciclovir, and all of them received symptomatic and supportive treatment, with good prognosis.
IM is more common in preschool children aged 3-6 years. There are differences in clinical characteristics among children of different ages. EBV antibody detection is helpful for diagnosis, and EBV-DNA detection can be used for diagnosis and evaluation of the disease, which is worthy of promotion. Clinical treatment with ganciclovir antiviral and symptomatic treatment, the curative effect and prognosis are good.
To explore the clinical efficacy of Bufei Yishen prescription in the treatment of patients with stable chronic obstructive pulmonary disease (COPD).
A total of 120 patients with stable COPD diagnosed and treated in our hospital were selected and randomly divided into the control group and the treatment group, 60 cases in each. The control group received conventional comprehensive treatment of western medicine, and the treatment group was treated with traditional Chinese medicine Bufei Yishen prescription on the basis of the control group. The traditional Chinese medicine (TCM) syndrome scores, pulmonary function index changes and adverse reactions were compared between the two groups after treatment.
After treatment, the TCM syndrome scores of cough, expectoration and wheezing in the two groups were significantly lower than those before treatment (P<0.05), and those in the treatment groups were lower than those in the control group (P<0.05). After treatment, the percentage of forced vital capacity (FVC) in the predicted value, the predicted value of forced expiratory volume in the first second (FEV1), and the value of FEV1/FVC in the two groups were significantly higher than those before treatment (P<0.05), and those in the treatment groups were lower than those in the control group (P<0.05). The total incidence of adverse reactions in the control group was 16.67% (10/60), and 13.33% (8/60) in the treatment group, and there was no significant difference in the incidence of adverse reactions between the two groups (χ2=1.872, P=0.609).
Bufei Yishen prescription combined with western medicine on stable COPD can improve the symptoms of patients, which is safe and effective, suitable for clinical application.
To explore the effect of Xingxiong sodium chloride injection combined with arotinolol hydrochloride tablets in the treatment of unstable angina pectoris (UAP).
A total of 92 UAP patients in our hospital from August 2018 to August 2021 were randomly divided into observation group and control group, with 46 cases in each group. Both groups were given basic treatment, the control group was given arotinolol hydrochloride tablets, and the observation group was treated with Xingxiong sodium chloride injection combined with arotinolol hydrochloride tablets. Treatment effect was evaluated after 2 weeks of treatment. The incidence of adverse reactions during the treatment period was calculated. Angina pectoris were counted before treatment, 1 week and 2 weeks after treatment in the two groups. Heart function, oxidation-antioxidant indexes, stromal cell-derived factor-1 (SDF-1), chemokine receptor 7 (CXCR7) were measured.
The efficacy evaluation results of the two groups showed that the observation group was higher than the control group (P<0.05). After 1 and 2 weeks of treatment, angina pectoris frequency, duration, visual analog scale score and weekly nitroglycerin consumption in the observation group were lower than those in the control group, left ventricular ejection fraction, cardiac index, the blood transfusion volume per stroke in the observation group were higher than those in the control group (P<0.05). After 1 and 2 weeks of treatment, malondialdehyde, lipid peroxide, SDF-1, and CXCR7 in the observation group were lower than those in the control group, and superoxide dismutase was higher than that in the control group (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the observation group and the control group (P>0.05).
Xingxiong sodium chloride injection combined with arotinolol hydrochloride tablets can alleviate angina pectoris attack in UAP patients, improve heart function, restore oxidation-antioxidant balance, regulate SDF-1 and CXCR7 with significant effects and high safety.
To investigate the efficacy of Xueshuantong combined with clopidogrel and aspirin in the treatment of transient ischemic attack (TIA) and the prevention of ischemic stroke.
A total of 120 TIA patients admitted to the Department of Neurology of Wuhu NO.1 People's Hospital from October 2019 to March 2021 were selected, and randomly divided into intervention group and control group. The control group was treated with clopidogrel (75 mg each day) and aspirin (100 mg each day), and the intervention group was additionally treated with Xueshuantong on the basis of the control group, the course of the treatment was 2 weeks. ABCD3-Ⅰ score, blood coagulation index, blood lipid index, hemorheology index and the incidence of ischemic stroke were observed in both groups.
A total of 109 patients completed treatment, including 55 in the control group and 54 in the intervention group. After treatment, the ABCD3-Ⅰ score, total cholesterol (TC), triglyceride (TG), low density lipoprotein-cholesterol (LDL-C), fibrinogen (FIB), plasma viscosity and erythrocyte aggregation index in the two groups were decreased compared with those before treatment (P<0.05). The high density lipoprotein-cholesterol (HDL-C), thrombin time (TT) and activated partial thromboplastin time (APTT) were significantly higher than those before treatment (P<0.05). After treatment, the ABCD3-Ⅰ score, TG, TC, LDL-C, FIB, plasma viscosity and erythrocyte aggregation index in the intervention group were lower than those in the control group (P<0.05), and the HDL-C, TT and APTT were higher than those in the control group (P<0.05). The incidence of ischemic stroke in the intervention group was lower than that in the control group at 1 month and 3 months after onset (14.55% vs 1.85%, 10.91% vs 0.00%, P<0.05). There was no statistical difference in the incidence of adverse reactions between the two groups (P>0.05).
Xueshuantong combined with dual antiplatelet therapy can effectively improve blood lipid, blood coagulation and hemorheology, and reduce the risk of stroke.